Therefore, the role of NF2 mutations is more nuanced in breast cancer, as NF2 loss by way of the Hippo signaling pathway can both contribute to tumorigenesis in some cases but also inhibition of tumor growth in TNBC tumors. This evidence concerns the gene NF2 and breast cancer.